monitoring of iron status and haemoglobin whilst on treatment for anaemia of CKD
Last reviewed 01/2018
Monitoring of iron status and haemoglobin whilst on treatment for anaemia of chronic kidney disease (CKD):
- iron levels
- people with anaemia of CKD should not have iron levels checked earlier
than 1 week after receiving intravenous iron
- length of time to monitoring of iron status is dependent on the product used and the amount of iron given
- routine monitoring of iron stores to prevent iron overload using serum
ferritin should be at intervals of 1-3months
- people with anaemia of CKD should not have iron levels checked earlier
than 1 week after receiving intravenous iron
- monitoring haemoglobin levels
- every 2-4 weeks in the induction phase of erythropoietin stimulating agent (ESA) therapy
- every 1-3 months in the maintenance phase of ESA therapy
- more actively after an ESA dose adjustment
ESAs: dose and frequency
- When correcting anaemia of CKD, the dose and frequency of ESA should be:
- determined by the duration of action and route of administration of
the ESA
- adjusted to keep the rate of Hb increase between 10 and 20 g/litre/month
- determined by the duration of action and route of administration of
the ESA
Notes:
- in people treated with iron, serum ferritin levels should not rise above 800 micrograms/litre. In order to prevent this, review the dose of iron when serum ferritin levels reach 500micrograms/litre
Reference: